The Effects of ROCK Inhibitor on Prevention of Dexamethasone-Induced Glaucoma Phenotype in Human Trabecular Meshwork Cells
Translational Vision Science & Technology · 2023
DOI: 10.1167/tvst.12.12.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2023. Verfasst von Tilahun Ayane Debele und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Environmental Engineering, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Glaucoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Environmental Engineering, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, USA.
- Department of Ophthalmology, College of Medicine, University of Cincinnati, OH, USA.
Förderung
- NEI NIH HHS
Zitieren
APA
Debele, T. A., Mount, Z. F., Yuan, Y., Kao, W. W., & Park, Y. C. (2023). The Effects of ROCK Inhibitor on Prevention of Dexamethasone-Induced Glaucoma Phenotype in Human Trabecular Meshwork Cells. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.12.12.4
Vancouver
Debele TA, Mount ZF, Yuan Y, Kao WW, Park YC. The Effects of ROCK Inhibitor on Prevention of Dexamethasone-Induced Glaucoma Phenotype in Human Trabecular Meshwork Cells. Translational Vision Science & Technology. 2023. doi:10.1167/tvst.12.12.4
BibTeX
@article{Debele2023,
author = {Debele, Tilahun Ayane and Mount, Zachary F and Yuan, Yong and Kao, Winston W-Y and Park, Yoonjee C},
title = {The Effects of ROCK Inhibitor on Prevention of Dexamethasone-Induced Glaucoma Phenotype in Human Trabecular Meshwork Cells},
journal = {Translational Vision Science & Technology},
year = {2023},
doi = {10.1167/tvst.12.12.4}
}
EUVIMED